M&A Deal Summary

Limerston Capital Acquires Astoriom

On January 17, 2024, private equity firm Limerston Capital acquired life science company Astoriom from SourceBio

Acquisition Highlights
  • This is Limerston Capital’s 3rd transaction in the Life Science sector.
  • This is Limerston Capital’s 12th transaction in the United Kingdom.

M&A Deal Summary

Date 2024-01-17
Target Astoriom
Sector Life Science
Buyer(s) Limerston Capital
Sellers(s) SourceBio
Deal Type Divestiture

Target

Astoriom

Rochdale, United Kingdom
Astoriom is a provider of temperature- and humidity- controlled storage solutions, and equipment services for stability trials, retained samples and long-term storage of biologic samples. The company offers storage, manufacturing, service, and validation solutions for pharmaceutical and biotechnology companies, contract manufacturers, and analytical testing companies worldwide. Astoriom is based in Rochdale, United Kingdom.

Search 214,981 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Limerston Capital

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2011
PE ASSETS 300M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Limerston Capital is a private equity firm focused on control investments in UK-based businesses valued from £50 to £175 million. In addition to providing capital, Limerston looks to be a hands-on investor, working closely with management in company operations as well as pursuing growth opportunities through acquisitions and other strategies. Limerston Capital was formed in 2011 and is headquartered in London.


DEAL STATS #
Overall 13 of 14
Sector: Life Science M&A 3 of 3
Type: Divestiture M&A Deals 3 of 3
Country: United Kingdom M&A 12 of 13
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-04-03 Concept Life Sciences

High Peak, United Kingdom

Concept Life Sciences is a global contract research organization primarily serving the pharmaceutical and life sciences research and development market. With an excellent track record in project execution, delivering tangible value for customers’ IP generation, and a stringent focus on quality. Concept Life Sciences was founded in 1989 and is based in High Peak, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-10 Village Bakery

Wrexham, United Kingdom

Village Bakery produces premium private label baked goods at scale for leading brands across the retail, hospitality and food service sectors in the UK.Village Bakery provided with exceptional products, unmatched innovation and peerless service levels. Village Bakery was founded in 1934 and is based in Wrexham, United Kingdom.

Sell -

Seller(S) 1

SELLER

SourceBio

Nottingham, United Kingdom

Category Company
Founded 2016
Sector Life Science
Revenue 51M GBP (2020)
DESCRIPTION

SourceBio is a provider of integrated state-of-the-art laboratory services and products. The Company also provides ISO15189 certified and United Kingdom Accreditation Service (UKAS) accredited diagnostic testing and cellular pathology services to the U.K.'s National Health Service (NHS) and other healthcare providers. SourceBio was founded in 2016 and is headquartered in Nottingham, England.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-29 LDPath

London, United Kingdom

LDPath is a provider of digital pathology testing services. The Company also provides rapid histopathology reporting by specialist pathologists, delivering a surgical pathology service to 300 hospitals with a growing international presence. LDPath was founded in 2011 and is based in London, England.

Buy -